Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

LMAT

LEMAITRE VASCULAR INC

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1158895Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$250.0M
Net Income FY2025
$58.0M
EPS (Basic, as reported)
$2.55
Net Margin FY2025
23.1%
ROE FY2025
14.7%
Total Equity
$394.0M
Shares Out
23M
Business description

LEMAITRE VASCULAR INC — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 89 → 250 +12.2% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue89101106117129154162193220250
Cost of revenue(26)(30)(32)(37)(45)(53)(57)(66)(69)(71)
Gross profit6371748085101105127151179
Research & development(6)(7)(8)(9)(10)(12)(13)(17)(16)(14)
Selling & marketing(26)(26)(27)(30)(24)(28)(33)(41)(47)(54)
General & administrative(14)(17)(18)(19)(23)(26)(29)(32)(36)(42)
Total operating expenses(47)(50)(46)(59)(56)(65)(78)(90)(99)(111)
Operating income16212821293627375268
Interest expense0000(1)(2)000(5)
Interest & investment income00110013513
Other income (expense), net————00000(1)
Pre-tax income16212822273427395775
Income tax expense(6)(4)(6)(4)(6)(7)(7)(9)(13)(17)
Net income11172318212721304458
EPS — basic$0.57$0.91$1.18$0.91$1.05$1.27$0.94$1.36$1.96$2.55
EPS — diluted$0.55$0.86$1.13$0.88$1.04$1.25$0.93$1.34$1.93$2.52
Shares outstanding — basic (M)18191920202122222223
Shares outstanding — diluted (M)19202020202122222323

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.